Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Gs-7340
2. Gs-734003
3. L-alanine, N-((s)-(((1r)-2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinyl)-, 1-methylethyl Ester
4. Tenofovir Alafenamide
1. Tenofovir Alafenamide Fumarate
2. 1392275-56-7
3. Gs-7340 Hemifumarate
4. Tenofovir Alafenamide Hemifumarate
5. Gs-7340-03
6. Tenofovir Alafenamide Fumarate [usan]
7. Fwf6q91tzo
8. Gs-7340 (hemifumarate)
9. Vemlidy (tn)
10. Taf
11. Chembl2364637
12. Chebi:90923
13. Dtxsid401027740
14. (s)-isopropyl 2-(((s)-((((r)-1-(6-amino-9h-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)propanoate Fumarate(2:1)
15. Ex-a2641
16. Mfcd30534429
17. S4427
18. Ac-30255
19. Tenofovir Alafenamide Fumarate (usan/jan)
20. Tenofovir Alafenamide Fumarate [mi]
21. Tenofovir Alafenamide Fumarate [jan]
22. Tenofovir Alafenamide Fumarate (2:1)
23. D10605
24. Tenofovir Alafenamide Fumarate [who-dd]
25. Tenofovir Alafenamide Fumarate [orange Book]
26. Descovy Component Tenofovir Alafenamide Fumarate
27. Odefsey Component Tenofovir Alafenamide Fumarate
28. Q27162911
29. Symtuza Component Tenofovir Alafenamide Fumarate
30. Biktarvy Component Tenofovir Alafenamide Fumarate
31. Tenofovir Alafenamide Fumarate Component Of Biktarvy
32. Tenofovir Alafenamide Fumarate Component Of Descovy
33. Tenofovir Alafenamide Fumarate Component Of Genvoya
34. Tenofovir Alafenamide Fumarate Component Of Odefsey
35. Tenofovir Alafenamide Fumarate Component Of Symtuza
36. (s)-isopropyl 2-(((s)-((((r)-1-(6-amino-9h-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)propanoate Hemifumarate
37. 1-methylethyl N-((s)-(((1r)-2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl(phenoxyphosphinoyl)-l-alaninate, (2e)-2-butenedioate
38. Bis{9-[(2r,5s,7e)-2,7,10-trimethyl-5,8-dioxo-5-phenoxy-3,9-dioxa-6-aza-5lambda5-phosphaundecan-1-yl]-9h-purin-6-aminium} (2e)-but-2-enedioate
39. Bis{propan-2-yl N-[(s)-({[(2r)-1-(6-amino-9h-purin-9-yl)propan-2-yl]oxy}methyl)(phenoxy)phosphoryl]-l-alaninate} (2e)-but-2-enedioate
Molecular Weight | 1069.0 g/mol |
---|---|
Molecular Formula | C46H62N12O14P2 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 24 |
Rotatable Bond Count | 26 |
Exact Mass | 1068.39836869 g/mol |
Monoisotopic Mass | 1068.39836869 g/mol |
Topological Polar Surface Area | 362 Ų |
Heavy Atom Count | 74 |
Formal Charge | 0 |
Complexity | 799 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Vemlidy is indicated for the treatment of chronic hepatitis B in adults and adolescents (aged 12 years and older with body weight at least 35 kg).
J05AF
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Market Place
Patents & EXCLUSIVITIES
ANALYTICAL
ABOUT THIS PAGE
A Tenofovir Alafenamide Fumarate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tenofovir Alafenamide Fumarate, including repackagers and relabelers. The FDA regulates Tenofovir Alafenamide Fumarate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tenofovir Alafenamide Fumarate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tenofovir Alafenamide Fumarate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tenofovir Alafenamide Fumarate supplier is an individual or a company that provides Tenofovir Alafenamide Fumarate active pharmaceutical ingredient (API) or Tenofovir Alafenamide Fumarate finished formulations upon request. The Tenofovir Alafenamide Fumarate suppliers may include Tenofovir Alafenamide Fumarate API manufacturers, exporters, distributors and traders.
click here to find a list of Tenofovir Alafenamide Fumarate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tenofovir Alafenamide Fumarate DMF (Drug Master File) is a document detailing the whole manufacturing process of Tenofovir Alafenamide Fumarate active pharmaceutical ingredient (API) in detail. Different forms of Tenofovir Alafenamide Fumarate DMFs exist exist since differing nations have different regulations, such as Tenofovir Alafenamide Fumarate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tenofovir Alafenamide Fumarate DMF submitted to regulatory agencies in the US is known as a USDMF. Tenofovir Alafenamide Fumarate USDMF includes data on Tenofovir Alafenamide Fumarate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tenofovir Alafenamide Fumarate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tenofovir Alafenamide Fumarate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Tenofovir Alafenamide Fumarate Drug Master File in Korea (Tenofovir Alafenamide Fumarate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Tenofovir Alafenamide Fumarate. The MFDS reviews the Tenofovir Alafenamide Fumarate KDMF as part of the drug registration process and uses the information provided in the Tenofovir Alafenamide Fumarate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Tenofovir Alafenamide Fumarate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Tenofovir Alafenamide Fumarate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Tenofovir Alafenamide Fumarate suppliers with KDMF on PharmaCompass.
A Tenofovir Alafenamide Fumarate written confirmation (Tenofovir Alafenamide Fumarate WC) is an official document issued by a regulatory agency to a Tenofovir Alafenamide Fumarate manufacturer, verifying that the manufacturing facility of a Tenofovir Alafenamide Fumarate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Tenofovir Alafenamide Fumarate APIs or Tenofovir Alafenamide Fumarate finished pharmaceutical products to another nation, regulatory agencies frequently require a Tenofovir Alafenamide Fumarate WC (written confirmation) as part of the regulatory process.
click here to find a list of Tenofovir Alafenamide Fumarate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tenofovir Alafenamide Fumarate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tenofovir Alafenamide Fumarate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tenofovir Alafenamide Fumarate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tenofovir Alafenamide Fumarate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tenofovir Alafenamide Fumarate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tenofovir Alafenamide Fumarate suppliers with NDC on PharmaCompass.
Tenofovir Alafenamide Fumarate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tenofovir Alafenamide Fumarate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tenofovir Alafenamide Fumarate GMP manufacturer or Tenofovir Alafenamide Fumarate GMP API supplier for your needs.
A Tenofovir Alafenamide Fumarate CoA (Certificate of Analysis) is a formal document that attests to Tenofovir Alafenamide Fumarate's compliance with Tenofovir Alafenamide Fumarate specifications and serves as a tool for batch-level quality control.
Tenofovir Alafenamide Fumarate CoA mostly includes findings from lab analyses of a specific batch. For each Tenofovir Alafenamide Fumarate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tenofovir Alafenamide Fumarate may be tested according to a variety of international standards, such as European Pharmacopoeia (Tenofovir Alafenamide Fumarate EP), Tenofovir Alafenamide Fumarate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tenofovir Alafenamide Fumarate USP).
LOOKING FOR A SUPPLIER?